Build a lasting personal brand

Redwood AI Corp. Gains DTC Eligibility, Engages InvestorBrandNetwork for Awareness Campaign

By Advos
Redwood AI Corp. announced DTC eligibility for its common shares and a $114,000 engagement with InvestorBrandNetwork for market awareness services through 2026.

Found this article helpful?

Share it with your network and spread the knowledge!

Redwood AI Corp. Gains DTC Eligibility, Engages InvestorBrandNetwork for Awareness Campaign

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) has announced that its common shares have been approved for electronic clearing and settlement through the Depository Trust Company (DTC), a move expected to simplify trading for U.S. investors and enhance liquidity. CEO Louis Dron stated that DTC eligibility improves access for U.S. investors and brokerage firms by enabling more efficient electronic clearing and settlement.

In a separate announcement, Redwood AI disclosed that it has engaged InvestorBrandNetwork (IBN) to provide market awareness, corporate communications, and digital media services. The engagement, effective through September 30, 2026, or until the allocated budget is exhausted, includes editorial coverage, newsletter distribution, social media support, and podcast syndication. Redwood will pay IBN an aggregate cash fee of $114,000 for these services, with no securities issued as compensation.

This development is significant for Redwood AI and its investors as DTC eligibility is a key milestone for companies trading on U.S. markets. It allows shares to be transferred electronically, reducing settlement times and costs, and broadening the pool of potential investors. For Redwood AI, which focuses on using artificial intelligence to accelerate chemistry R&D and drug discovery, increased liquidity and market access could support its growth objectives.

The engagement with IBN, a specialized communications platform under the Dynamic Brand Portfolio, aims to raise awareness of Redwood AI's platform, which combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. The company's technology is designed to enable faster, more efficient development of new therapies and chemistry-driven applications, including defense and safety solutions.

Investors should note that the press release announcing these developments was disseminated on behalf of Redwood AI Corp. and may include paid advertising. The full press release is available at https://ibn.fm/Yga70. More information about Redwood AI can be found at https://redwoodai.com/.

Advos

Advos

@advos